Literature DB >> 7779715

Abnormal pattern of post-gamma-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome.

R Mirzayans1, R A Aubin, W Bosnich, W A Blattner, M C Paterson.   

Abstract

Non-malignant dermal fibroblast strains, cultured from affected members of a Li-Fraumeni syndrome (LFS) family with diverse neoplasms associated with radiation exposure, display a unique increased resistance to the lethal effects of gamma-radiation. In the studies reported here, this radioresistance (RR) trait has been found to correlate strongly with an abnormal pattern of post-gamma-ray DNA replicative synthesis, as monitored by radiolabelled thymidine incorporation and S-phase cell autoradiography. In particular, the time interval between the gamma-ray-induced shutdown of DNA synthesis and its subsequent recovery was greater in all four RR strains examined and the post-recovery replication rate was much higher and was maintained longer than in normal and spousal controls. Alkaline sucrose sedimentation profiles of pulse-labelled cellular DNA indicated that the unusual pattern of DNA replication in irradiated RR strains may be ascribed to anomalies in both replicon initiation and DNA chain elongation processes. Moreover, the RR strain which had previously displayed the highest post-gamma-ray clonogenic survival was found to harbour a somatic (codon 234) mutation (presumably acquired during culture in vitro) in the same conserved region of the p53 tumour-suppressor gene as the germline (codon 245) mutation in the remaining three RR strains from other family members, thus coupling the RR phenotype and abnormal post-gamma-ray DNA synthesis pattern with faulty p53 expression. Significantly, these two aberrant radioresponse end points, along with documented anomalies in c-myc and c-raf-1 proto-oncogenes, are unprecedented among other LFS families carrying p53 germline mutations. We thus speculate that this peculiar cancer-prone family may possess in its germ line a second, as yet unidentified, genetic defect in addition to the p53 mutation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779715      PMCID: PMC2033854          DOI: 10.1038/bjc.1995.237

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  44 in total

Review 1.  myc function and regulation.

Authors:  K B Marcu; S A Bossone; A J Patel
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

2.  Effects of ionizing radiation on DNA replication in cultured mammalian cells.

Authors:  F Makino; S Okada
Journal:  Radiat Res       Date:  1975-04       Impact factor: 2.841

3.  Defective excision repair of gamma-ray-damaged DNA in human (ataxia telangiectasia) fibroblasts.

Authors:  M C Paterson; B P Smith; P H Lohman; A K Anderson; L Fishman
Journal:  Nature       Date:  1976-04-01       Impact factor: 49.962

4.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

5.  Radiosensitivity in ataxia-telangiectasia: a new explanation.

Authors:  R B Painter; B R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

6.  Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells.

Authors:  J Houldsworth; M F Lavin
Journal:  Nucleic Acids Res       Date:  1980-08-25       Impact factor: 16.971

7.  Genealogy of cancer in a family.

Authors:  W A Blattner; D B McGuire; J J Mulvihill; B C Lampkin; J Hananian; J F Fraumeni
Journal:  JAMA       Date:  1979-01-19       Impact factor: 56.272

8.  Transmission of in-vitro radioresistance in a cancer-prone family.

Authors:  N T Bech-Hansen; W A Blattner; B M Sell; E A McKeen; B C Lampkin; J F Fraumeni; M C Paterson
Journal:  Lancet       Date:  1981-06-20       Impact factor: 79.321

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  The rate of DNA synthesis in normal human and ataxia telangiectasia cells after exposure to X-irradiation.

Authors:  J de Wit; N G Jaspers; D Bootsma
Journal:  Mutat Res       Date:  1981-01       Impact factor: 2.433

View more
  7 in total

1.  Effects of the protein kinase inhibitors wortmannin and KN62 on cellular radiosensitivity and radiation-activated S phase and G1/S checkpoints in normal human fibroblasts.

Authors:  L Enns; D Murray; R Mirzayans
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

2.  Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations.

Authors:  J M Boyle; M J Greaves; R S Camplejohn; J M Birch; S A Roberts; J M Varley
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

3.  Differential S-phase progression after irradiation of p53 functional versus non-functional tumour cells.

Authors:  Friedo Zölzer; Tamare Mußfeldt; Christian Streffer
Journal:  Radiol Oncol       Date:  2014-11-05       Impact factor: 2.991

4.  Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families.

Authors:  J M Boyle; E L Mitchell; M J Greaves; S A Roberts; K Tricker; E Burt; J M Varley; J M Birch; D Scott
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

5.  Presence of a heterozygous substitution and its relationship to DT-diaphorase activity.

Authors:  B L Kuehl; J W Paterson; J W Peacock; M C Paterson; A M Rauth
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

6.  Molecular cloning, genomic characterization and over-expression of a novel gene, XRRA1, identified from human colorectal cancer cell HCT116Clone2_XRR and macaque testis.

Authors:  Felix M Mesak; Naoki Osada; Katsuyuki Hashimoto; Qing Y Liu; Cheng E Ng
Journal:  BMC Genomics       Date:  2003-08-09       Impact factor: 3.969

Review 7.  Ionizing radiation-induced responses in human cells with differing TP53 status.

Authors:  Razmik Mirzayans; Bonnie Andrais; April Scott; Ying W Wang; David Murray
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.